Water → 2-[4-Chloro-5-phenyl-3-(trifluoromethyl)pyrazolo[3,4-c]pyridazin-1-yl]-1-pyrrolidin-1-yl-ethanone

HRID 2205790Notes

Reaction equation

HRID 2205790 reaction equation
[H-].[Na+].[Cl:3][C:4]1[C:9]([C:10]2[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=2)=[N:8][N:7]=[C:6]2[NH:16][N:17]=[C:18]([C:19]([F:22])([F:21])[F:20])[C:5]=12.Cl[CH2:24][C:25]([N:27]1[CH2:31][CH2:30][CH2:29][CH2:28]1)=[O:26].O>CN(C=O)C.C(Cl)Cl>[Cl:3][C:4]1[C:9]([C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][CH:15]=2)=[N:8][N:7]=[C:6]2[N:16]([CH2:24][C:25]([N:27]3[CH2:31][CH2:30][CH2:29][CH2:28]3)=[O:26])[N:17]=[C:18]([C:19]([F:22])([F:20])[F:21])[C:5]=12

Participants

7

Procedure

Sodium hydride (18 mg, 0.45 mmol) was added to a solution of 4-chloro-5-phenyl-3-(trifluoromethyl)-1H-pyrazolo[3,4-c]pyridazine (115 mg, 0.38 mmol) and 2-chloro-1-pyrrolidin-1-yl-ethanone (81 mg, 0.55 mmol) in dry DMF (1.5 ml) and the reaction stirred for 21 h. Water and CH2Cl2 where added and the aqueous phase was extracted with CH2Cl2. The organic phases where combined, dried over MgSO4, filtered and evaporated. The residue was purified by column chromatography (silica gel, ethyl acetate/isohexane 2:8 to 1:0) followed by preparative HPLC yielding Compound Iaa as a white solid (23 mg).

Workup

  1. extractionthe aqueous phase was extracted with CH2Cl2
  2. dry with materialdried over MgSO4
  3. filtrationfiltered
  4. customevaporated
  5. customThe residue was purified by column chromatography (silica gel, ethyl acetate/isohexane 2:8 to 1:0)

Sources & evidence

ORD record
ord-30e30366d0ee4adba853c24b87c3e70d
Source dataset
uspto-grants-2016_06
Patent number
US09371332B2

Reaction notes

Loading…